Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Acute Toxicity: oral

Currently viewing:

Administrative data

Endpoint:
acute toxicity: oral
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1987
Report date:
1987

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
EU Method B.1 (Acute Toxicity (Oral))
Version / remarks:
Cited as Directive 84/449/EEC, B.1
GLP compliance:
yes
Remarks:
Bayer AG, Institute of Toxicology
Test type:
standard acute method

Test material

Constituent 1
Chemical structure
Reference substance name:
ε-caprolactam
EC Number:
203-313-2
EC Name:
ε-caprolactam
Cas Number:
105-60-2
Molecular formula:
C6H11NO
IUPAC Name:
azepan-2-one
Specific details on test material used for the study:
- Name of test material (as cited in study report): epsilon-Caprolactam
- Physical state: solid
- Analytical purity: 99.9%

Test animals

Species:
rat
Strain:
Wistar
Sex:
male/female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Source: Winkelmann, Borchen
- Age at study initiation: male 9 weeks, female 14 weeks
- Mean weight at study initiation: male 182 g, female 170 g
- Fasting period before study: 16 h before dosing
- Housing: 5 per cage
- Diet (e.g. ad libitum): Altromin 1324 pellets
- Water (e.g. ad libitum): tap water
- Acclimation period: 5 days


ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22±2
- Humidity (%): 50±10
- Air changes (per hr): 10
- Photoperiod (hrs dark / hrs light): 12/12

Administration / exposure

Route of administration:
oral: gavage
Vehicle:
water
Details on oral exposure:
VEHICLE
- Amount of vehicle (if gavage): 10 ml/kg bw

Doses:
male: 0, 312, 1000, 1250, 1600, 2000, 2250 mg/kg bw
female: 0, 312, 1000, 1250, 1600, 2000 mg/kg bw
No. of animals per sex per dose:
5
Control animals:
no
Details on study design:
- Duration of observation period following administration: 14 days
- Frequency of observations and weighing: several times on the day of application and daily thereafter. Body weights were recorded before application, 7 d post application and at the end of the observation period.
- Necropsy of survivors performed: yes
Statistics:
Rosiello et al., J. Tox. Environ. Health 3, 797, 1977.

Results and discussion

Effect levelsopen allclose all
Sex:
female
Dose descriptor:
LD50
Effect level:
1 475 mg/kg bw
95% CL:
1 216 - 1 789
Sex:
male
Dose descriptor:
LD50
Effect level:
1 876 mg/kg bw
95% CL:
1 359 - 2 590
Mortality:
Mortality was observed (see table 1 and 2).
Clinical signs:
other: 1250 - 2250 mg/kg bw: clonic convulsion, piloerection, salivation, dyspnoea, tremor, high stepping gait, nose discharge, hollow flanks. The signs were observed till 7 days of the observation period. In the females of 1000 mg/kg bw dose group, slight gasp
Gross pathology:
Deceased animals: redness in the lungs and gastro-intestinal tract, enlarged liver
Sacrificed animals: no abnormalities were detected

Any other information on results incl. tables

Table 1: Mortality rate in males

Dose (mg/kg bw)

Mortality rate

Died within

312

0/5

-

1000

0/5

-

1250

0/5

-

1600

3/5

6 h

2000

2/5

4 h

2250

4/5

5 h

Table 2: Mortality rates in females

Dose (mg/kg bw)

Mortality rate

Died within

312

0/5

-

1000

1/5

3 h

1250

0/5

-

1600

4/5

6 h

2000

4/5

4 h

Applicant's summary and conclusion

Interpretation of results:
Category 4 based on GHS criteria
Conclusions:
The LD50 for male and female rats was reported to be 1876 and 1475 mg/kg bw, respectively.
Executive summary:

This study was performed according to guideline and GLP. The LD50 for male and female rats was reported to be 1876 and 1475 mg/kg bw, respectively. Significant mortality was observed from the dose level of 1600 mg/kg bw within 6 h after exposure. Clinical signs were clonic convulsion, piloerection, salivation, dyspnoea, tremor, high stepping gait, nose discharge, hollow flanks. The signs were persistent until the end of the 7 days observation period. At necropsy, redness in the lungs and gastro-intestinal tract, and enlarged liver were described.